Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
ObesityNeoplasms
Interventions
DRUG

Xeloda

"Cycle 1: Days 1-7 (21 day cycle): 1250 mg/m2 Xeloda orally twice a day using Ideal Body Weight to calculate dosage. Cycle 1, Day 8-No drug.~Cycle 1: Days 9-15 (21 day cycle): 1250 mg/m2 Xeloda orally twice a day using Actual Body Weight to calculate dosage. Days 16-21-No drug.~Cycle 2 and greater: Days 1-14 (21 day cycle): 1250 mg/m2 Xeloda orally twice a day using Actual Body Weight to calculate dosage."

Trial Locations (1)

53792

University of Wisconsin-Carbone Cancer Center, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT01828554 - Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight | Biotech Hunter | Biotech Hunter